MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-07-2026
Soleno Therapeutics Market Cap 2011-2026 | SLNO
As of May 15, 2026 Soleno Therapeutics has a market cap of $ 2.69 B
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Soleno Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.08 B | 1.96 B | 803 M | 17.4 M | 1.89 M | 156 M | 110 M | 36.1 M | 15.6 M | 13.1 M | 12.6 M | 1.69 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.08 B | 1.69 M | 434 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Diagnostics research industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
221 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
2.95 B | $ 18.56 | - | $ 196 M |  China |
 |
Agilent Technologies
A
|
42 B | $ 113.26 | - | $ 34.4 B |  USA |
 |
Co-Diagnostics
CODX
|
5.85 M | $ 1.63 | - | $ 2.17 M | USA |
 |
Castle Biosciences
CSTL
|
472 M | $ 18.88 | - | $ 547 M | USA |
|
Akumin
AKU
|
75.1 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
467 M | $ 16.19 | - | $ 490 M | USA |
 |
Aspira Women's Health
AWH
|
45.4 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
40.3 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
5.93 M | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
421 M | - | - | $ 562 M |  Britain |
 |
Interpace Biosciences
IDXG
|
7.34 M | $ 1.8 | -5.26 % | $ 7.96 M | USA |
 |
CareDx, Inc
CDNA
|
993 M | $ 20.49 | - | $ 1.09 B | USA |
 |
Chembio Diagnostics
CEMI
|
12.6 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
4.33 M | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
2.99 M | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
5.12 B | $ 96.67 | - | $ 6.52 B | USA |
 |
Medpace Holdings
MEDP
|
13 B | $ 419.17 | - | $ 12.1 B | USA |
 |
Global Cord Blood Corporation
CO
|
243 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
481 M | - | 1.08 % | $ 308 M | USA |
 |
Mettler-Toledo International
MTD
|
28.4 B | $ 1 041.91 | - | $ 21.5 B |  Schweiz |
 |
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
1.54 B | - | 0.12 % | $ 80.1 M | China |
 |
Myriad Genetics
MYGN
|
409 M | $ 3.62 | - | $ 335 M | USA |
 |
DermTech
DMTK
|
42.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
NeoGenomics
NEO
|
1.48 B | $ 8.36 | - | $ 1.07 B | USA |
 |
National Research Corporation
NRC
|
315 M | $ 18.93 | - | $ 424 M | USA |
 |
Natera
NTRA
|
5.31 B | $ 196.91 | - | $ 19.4 B | USA |
 |
Charles River Laboratories International
CRL
|
7.69 B | $ 159.12 | - | $ 7.89 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
7.87 B | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
57.5 K | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
19.5 B | - | - | $ 19.8 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
30.3 B | $ 25.5 | - | $ 24.2 B |  Niderland |
 |
Guardant Health
GH
|
13.4 B | $ 98.66 | - | $ 12.4 B | USA |
 |
Senseonics Holdings
SENS
|
351 M | $ 5.82 | - | $ 243 M | USA |
 |
Personalis
PSNL
|
431 M | $ 6.71 | - | $ 599 M | USA |
 |
Heska Corporation
HSKA
|
844 M | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
16.6 B | $ 117.09 | - | $ 9.66 B |  Irlanda |
 |
Illumina
ILMN
|
16.4 B | $ 143.24 | - | $ 22.8 B | USA |
 |
QIAGEN N.V.
QGEN
|
8.52 B | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
7.19 M | $ 2.41 | - | $ 5.54 M | USA |
 |
Thermo Fisher Scientific
TMO
|
196 B | $ 448.21 | - | $ 169 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
23.9 B | $ 254.02 | - | $ 21.1 B | USA |
 |
Trinity Biotech plc
TRIB
|
194 M | $ 0.58 | - | $ 208 M | Irlanda |
 |
Celcuity
CELC
|
5.37 B | $ 134.72 | - | $ 6.3 B | USA |
 |
Motus GI Holdings
MOTS
|
990 K | - | -34.28 % | $ 263 K | Israel |
 |
Twist Bioscience Corporation
TWST
|
1.56 B | $ 52.95 | - | $ 3.17 B | USA |
 |
Neogen Corporation
NEOG
|
1.02 B | $ 8.43 | - | $ 1.83 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
23.3 B | $ 187.94 | - | $ 20.9 B | USA |